logo-loader

Open Orphan PLC

Receive alerts
Market:
AIM
Market Cap:
£16.29 m
Price
6.40 GBX
Change
-2.29%
52 weeks high
8.15
52 weeks low
4.64

In brief

Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug focused pharma services company by a management team with extensive industry and financial expertise. Open Orphan is listed on both the London and Dublin stock exchanges.

The company is divided into three divisions;

  • Open Orphan Services
  • Open Orphan Virtual Rep
  • Open Orphan Health Data
     

Deep dive We explore the investor case for growth companies

Snapshot

  • Open Orphan reversed into Venn Life Sciences in June 2019
  • The plan was to establish one of Europe’s most comprehensive rare disease patient databases
  • Merger with hVIVO completed in January 2020 to create European full pharma services company